PacificHealth Laboratories Inc
PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; E… Read more
Market Cap & Net Worth: PacificHealth Laboratories Inc (PHLI)
PacificHealth Laboratories Inc (PINK:PHLI) has a market capitalization of $2.09K ($2.09K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51498 globally and #16168 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PacificHealth Laboratories Inc's stock price $0.00 by its total outstanding shares 20871800 (20.87 Million).
PacificHealth Laboratories Inc Market Cap History: 2015 to 2024
PacificHealth Laboratories Inc's market capitalization history from 2015 to 2024. Data shows change from $208.72K to $2.09K (-45.41% CAGR).
PacificHealth Laboratories Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PacificHealth Laboratories Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PHLI by Market Capitalization
Companies near PacificHealth Laboratories Inc in the global market cap rankings as of March 18, 2026.
Key companies related to PacificHealth Laboratories Inc by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #35 globally with a market cap of $351.41 Billion USD.
- Unilever PLC (PINK:UNLYF): Ranked #141 globally with a market cap of $131.81 Billion USD.
- UNILEVER PLC LS -,035 (XETRA:UNV0): Ranked #147 globally with a market cap of $126.11 Billion USD ( €122.86 Billion EUR).
- L'Oréal S.A (PINK:LRLCF): Ranked #215 globally with a market cap of $94.58 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #35 | Procter & Gamble Company | NYSE:PG | $351.41 Billion | $151.48 |
| #141 | Unilever PLC | PINK:UNLYF | $131.81 Billion | $60.96 |
| #147 | UNILEVER PLC LS -,035 | XETRA:UNV0 | $126.11 Billion | €56.81 |
| #215 | L'Oréal S.A | PINK:LRLCF | $94.58 Billion | $368.10 |
PacificHealth Laboratories Inc Historical Marketcap From 2015 to 2024
Between 2015 and today, PacificHealth Laboratories Inc's market cap moved from $208.72K to $ 2.09K, with a yearly change of -45.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $2.09K | 0.00% |
| 2023 | $2.09K | -98.00% |
| 2022 | $104.36K | +4900.00% |
| 2021 | $2.09K | -99.34% |
| 2020 | $315.16K | +51.00% |
| 2019 | $208.72K | +96.08% |
| 2018 | $106.45K | -50.00% |
| 2017 | $212.89K | -32.00% |
| 2016 | $313.08K | +50.00% |
| 2015 | $208.72K | -- |
End of Day Market Cap According to Different Sources
On Nov 28th, 2025 the market cap of PacificHealth Laboratories Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.09K USD |
| MoneyControl | $2.09K USD |
| MarketWatch | $2.09K USD |
| marketcap.company | $2.09K USD |
| Reuters | $2.09K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.